The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

The only lab in the U.S. capable of testing for and tracking antibiotic-resistant gonorrhea, or “super gonorrhea,” was ...

A Mumbai-based doctor has reported that a young woman contracted hepatitis B after a threading procedure at a salon, ...

A study by the Stanford Prevention Policy Modeling Lab (PPML) finds that almost 30% of privately insured individuals in the United States, or nearly 40 million people, use at least one of the free ...

All 27 scientists at the CDC's viral hepatitis lab were told their duties were "unnecessary." Ongoing outbreak investigations ...

Florida health officials say three hepatitis C cases may have been caused by unsterilized instruments and/or equipment during ...

Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...

The highly contagious, vaccine-preventable disease inflames the liver and has seen rising outbreaks among men who have sex ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.

Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...

ShareHepatitis B remains one of the most pressing yet overlooked public health challenges worldwide. Affecting over 296 million people, this viral infection of the liver has long been labeled a ...